|
1
|
Campochiaro PA: Ocular neovascularization.
J Mol Med (Berl). 91:311–321. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee YM, Lee YR, Kim CS, Jo K, Sohn E, Kim
JS and Kim J: Cnidium officinale extract and butylidenephthalide
inhibits retinal neovascularization in vitro and in vivo. BMC
Complement Altern Med. 16:2312016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Multicenter trial of cryotherapy for
retinopathy of prematurity, . 3 1/2-Year outcome-structure and
function. Cryotherapy for retinopathy of prematurity cooperative
group. Arch Ophthalmol. 111:339–344. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Phelps DL: Retinopathy of prematurity.
Pediatr Rev. 16:50–56. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsilimbaris MK, Kontadakis GA, Tsika C,
Papageorgiou D and Charoniti M: Effect of panretinal
photocoagulation treatment on vision-related quality of life of
patients with proliferative diabetic retinopathy. Retina.
33:756–761. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ameri H, Liu H, Liu R, Ha Y,
Paulucci-Holthauzen AA, Hu S, Motamedi M, Godley BF, Tilton RG and
Zhang W: TWEAK/Fn14 pathway is a novel mediator of retinal
neovascularization. Invest Ophthalmol Vis Sci. 55:801–813. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Witmer AN, Vrensen GF, Van Noorden CJ and
Schlingemann RO: Vascular endothelial growth factors and
angiogenesis in eye disease. Prog Retin Eye Res. 22:1–29. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu W, Bai Y, Han N, Wang F, Zhao M, Huang
L and Li X: Inhibition of pathological retinal neovascularization
by semaphorin 3A. Mol Vis. 19:1397–1405. 2013.PubMed/NCBI
|
|
9
|
Praidou A, Androudi S, Brazitikos P,
Karakiulakis G, Papakonstantinou E and Dimitrakos S: Angiogenic
growth factors and their inhibitors in diabetic retinopathy. Curr
Diabetes Rev. 6:304–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Risau W: Mechanisms of angiogenesis.
Nature. 386:671–674. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gariano RF and Gardner TW: Retinal
angiogenesis in development and disease. Nature. 438:960–966. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang SX and Ma JX: Ocular
neovascularization: Implication of endogenous angiogenic inhibitors
and potential therapy. Prog Retin Eye Res. 26:1–37. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fong GH: Mechanisms of adaptive
angiogenesis to tissue hypoxia. Angiogenesis. 11:121–140. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liekens S, Schols D and Hatse S:
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell
mobilization. Curr Pharm Des. 16:3903–3920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Federsppiel B, Melhado IG, Duncan AM,
Delaney A, Schappert K, Clark-Lewis I and Jirik FR: Molecular
cloning of the cDNA and chromosomal localization of the gene for a
putative seven-transmembrane segment (7-TMS) receptor isolated from
human spleen. Genomics. 16:707–712. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nomura H, Nielsen BW and Matsushima K:
Molecular cloning of cDNAs encoding a LD78 receptor and putative
leukocyte chemotactic peptide receptors. Int Immunol. 5:1239–1249.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aiuti A, Webb IJ, Bleul C, Springer T and
Gutierrez-Ramos JC: The chemokine SDF-1 is a chemoattractant for
human CD34+ hematopoietic progenitor cells and provides a new
mechanism to explain the mobilization of CD34+ progenitors to
peripheral blood. J Exp Med. 185:111–120. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jo DY, Rafii S, Hamada T and Moore MA:
Chemotaxis of primitive hematopoietic cells in response to stromal
cell-derived factor-1. J Clin Invest. 105:101–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bleul CC, Fuhlbrigge RC, Casasnovas JM,
Aiuti A and Springer TA: A highly efficacious lymphocyte
chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med.
184:1101–1109. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pablos JL, Amara A, Bouloc A, Santiago B,
Caruz A, Galindo M, Delaunay T, Virelizier JL and
Arenzana-Seisdedos F: Stromal-cell derived factor is expressed by
dendritic cells and endothelium in human skin. Am J Pathol.
155:1577–1586. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin DK, Shido K, Kopp HG, Petit I,
Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B,
et al: Cytokine-mediated deployment of SDF-1 induces
revascularization through recruitment of CXCR4+ hemangiocytes. Nat
Med. 12:557–567. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu G, Lu P, Li L, Jin H, He X, Mukaida N
and Zhang X: Critical role of SDF-1α-induced progenitor cell
recruitment and macrophage VEGF production in the experimental
corneal neovascularization. Mol Vis. 17:2129–2138. 2011.PubMed/NCBI
|
|
23
|
Liu GQ, Lu PR, Li LB and Zhang XG:
Inhibited experimental corneal neovascularization by neutralizing
anti-SDF-1α antibody. Int J Ophthalmol. 5:7–12. 2012.PubMed/NCBI
|
|
24
|
Sonmez K, Drenser KA, Capone A Jr and
Trese MT: Vitreous levels of stromal cell-derived factor 1 and
vascular endothelial growth factor in patients with retinopathy of
prematurity. Ophthalmology. 115:1065–1070.e1. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Butler JM, Guthrie SM, Koc M, Afzal A,
Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB and Scott EW:
SDF-1 is both necessary and sufficient to promote proliferative
retinopathy. J Clin Invest. 115:86–93. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bhutto IA, McLeod DS, Merges C, Hasegawa T
and Lutty GA: Localisation of SDF-1 and its receptor CXCR4 in
retina and choroid of aged human eyes and in eyes with age related
macular degeneration. Br J Ophthalmol. 90:906–910. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lima e Silva R, Shen J, Hackett SF, Kachi
S, Akiyama H, Kiuchi K, Yokoi K, Hatara MC, Lauer T, Aslam S, et
al: The SDF-1/CXCR4 ligand/receptor pair is an important
contributor to several types of ocular neovascularization. FASEB J.
21:3219–3230. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sengupta N, Afzal A, Caballero S, Chang
KH, Shaw LC, Pang JJ, Bond VC, Bhutto I, Baba T, Lutty GA and Grant
MB: Paracrine modulation of CXCR4 by IGF-1 and VEGF: Implications
for choroidal neovascularization. Invest Ophthalmol Vis Sci.
51:2697–2704. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee E and Rewolinski D: Evaluation of
CXCR4 inhibition in the prevention and intervention model of
laser-induced choroidal neovascularization. Invest Ophthalmol Vis
Sci. 51:3666–3672. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Z, Liu G, Xiao Y and Lu P:
Adrenomedullin22-52 suppresses high-glucose-induced migration,
proliferation, and tube formation of human retinal endothelial
cells. Mol Vis. 20:259–269. 2014.PubMed/NCBI
|
|
31
|
Liu G, Zhang W, Xiao Y and Lu P: Critical
Role of IP-10 on reducing experimental corneal neovascularization.
Curr Eye Res. 40:891–901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chao TI, Xiang S, Chen CS, Chin WC, Nelson
AJ, Wang C and Lu J: Carbon nanotubes promote neuron
differentiation from human embryonic stem cells. Biochem Biophys
Res Commun. 384:426–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu P, Li L, Liu G, van Rooijen N, Mukaida
N and Zhang X: Opposite roles of CCR2 and CX3CR1 macrophages in
alkali-induced corneal neovascularization. Cornea. 28:562–569.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Farnoodian M, Wang S, Dietz J, Nickells
RW, Sorenson CM and Sheibani N: Negative regulators of
angiogenesis: Important targets for treatment of exudative AMD.
Clin Sci (Lond). 131:1763–1780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mao L, Huang M, Chen SC, Li YN, Xia YP, He
QW, Wang MD, Huang Y, Zheng L and Hu B: Endogenous endothelial
progenitor cells participate in neovascularization via CXCR4/SDF-1
axis and improve outcome after stroke. CNS Neurosci Ther.
20:460–468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li B, Bai W, Sun P, Zhou B, Hu B and Ying
J: The effect of CXCL12 on endothelial progenitor cells: Potential
target for angiogenesis in intracerebral hemorrhage. J Interferon
Cytokine Res. 35:23–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tu TC, Nagano M, Yamashita T, Hamada H,
Ohneda K, Kimura K and Ohneda O: A chemokine receptor, CXCR4, which
is regulated by hypoxia-inducible factor 2α, is crucial for
functional endothelial progenitor cells migration to ischemic
tissue and wound repair. Stem Cells Dev. 25:266–276. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang YB, Liu YF, Lu XT, Yan FF, Wang B,
Bai WW and Zhao YX: Rehmannia glutinosa extract activates
endothelial progenitor cells in a rat model of myocardial
infarction through a SDF-1 α/CXCR4 cascade. PLoS One. 8:e543032013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Griffioen AW and Molema G: Angiogenesis:
potentials for pharmacologic intervention in the treatment of
cancer, cardiovascular diseases, and chronic inflammation.
Pharmacol Rev. 52:237–268. 2000.PubMed/NCBI
|
|
41
|
Hsu YP, Staton CA, Cross N and Buttle DJ:
Anti-angiogenic properties of ADAMTS-4 in vitro. Int J Exp Pathol.
93:70–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lawler PR and Lawler J: Molecular basis
for the regulation of angiogenesis by thrombospondin-1 and −2. Cold
Spring Harb Perspect Med. 2:a0066272012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kryczek I, Wei S, Keller E, Liu R and Zou
W: Stroma-derived factor (SDF-1/CXCL12) and human tumor
pathogenesis. Am J Physiol Cell Physiol. 292:C987–C995. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Martínez A: A new family of angiogenic
factors. Cancer Lett. 236:157–163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Uno K, Hayashi H, Kuroki M, Uchida H,
Yamauchi Y, Kuroki M and Oshima K: Thrombospondin-1 accelerates
wound healing of corneal epithelia. Biochem Biophys Res Commun.
315:928–934. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sakaguchi I, Ikeda N, Nakayama M, Kato Y,
Yano I and Kaneda K: Trehalose 6,6′-dimycolate (Cord factor)
enhances neovascularization through vascular endothelial growth
factor production by neutrophils and macrophages. Infect Immun.
68:2043–2052. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Edelman JL, Castro MR and Wen Y:
Correlation of VEGF expression by leukocytes with the growth and
regression of blood vessels in the rat cornea. Invest Ophthalmol
Vis Sci. 40:1112–1123. 1999.PubMed/NCBI
|
|
48
|
Lai CM, Spilsbury K, Brankov M, Zaknich T
and Rakoczy PE: Inhibition of corneal neovascularization by
recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res.
75:625–634. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Newey SE, Tsaknakis G, Khoo CP,
Athanassopoulos T, Camicia R, Zhang Y, Grabowska R, Harris AL,
Roubelakis MG and Watt SM: The hematopoietic chemokine CXCL12
promotes integration of human endothelial colony forming
cell-derived cells into immature vessel networks. Stem Cells Dev.
23:2730–2743. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Smadja DM, Bièche I, Uzan G, Bompais H,
Muller L, Boisson-Vidal C, Vidaud M, Aiach M and Gaussem P: PAR-1
activation on human late endothelial progenitor cells enhances
angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.
Arterioscler Thromb Vasc Biol. 25:2321–2327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hamed S, Egozi D, Dawood H, Keren A,
Kruchevsky D, Ben-Nun O, Gilhar A, Brenner B and Ullmann Y: The
chemokine stromal cell-derived factor-1α promotes endothelial
progenitor cell-mediated neovascularization of human transplanted
fat tissue in diabetic immunocompromised mice. Plast Reconstr Surg.
132:239e–250e. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fernández JG, Rodríguez DA, Valenzuela M,
Calderon C, Urzúa U, Munroe D, Rosas C, Lemus D, Díaz N, Wright MC,
et al: Survivin expression promotes VEGF-induced tumor angiogenesis
via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription.
Mol Cancer. 13:2092014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Karar J and Maity A: PI3K/AKT/mTOR pathway
in angiogenesis. Front Mol Neurosci. 4:512011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barbero S, Bonavia R, Bajetto A, Porcile
C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and
Schettini G: Stromal cell-derived factor 1alpha stimulates human
glioblastoma cell growth through the activation of both
extracellular signal-regulated kinases 1/2 and Akt. Cancer Res.
63:1969–1974. 2003.PubMed/NCBI
|
|
55
|
Wu D, Guo X, Su J, Chen R, Berenzon D,
Guthold M, Bonin K, Zhao W and Zhou X: CD138-negative myeloma cells
regulate mechanical properties of bone marrow stromal cells through
SDF-1/CXCR4/AKT signaling pathway. Biochim Biophys Acta.
1853:338–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lin ML, Lu YC, Chen HY, Lee CC, Chung JG
and Chen SS: Suppressing the formation of lipid raft-associated
Rac1/PI3K/Akt signaling complexes by curcumin inhibits
SDF-1α-induced invasion of human esophageal carcinoma cells. Mol
Carcinog. 53:360–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
